Healthcare & Life Sciences
Triumvira Immunologies
Triumvira Immunologies is a series a startup based in United States. 1 investor tracked.
Activeseries-a
series-a
Stage
2018
Founded
1
Investors
About Triumvira Immunologies
Based in the United States, Triumvira Immunologies is a startup founded in 2018. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
The biotech company is developing T cell therapeutics to treat solid tumors.
Explore Triumvira Immunologies's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.